120800-50-2 Usage
Uses
Used in Pharmaceutical Industry:
6-PIPERIDINONIC ACID is used as a precursor in the synthesis of various pharmaceutical drugs and active ingredients for its potential therapeutic properties. It is particularly valuable in the development of new medications due to its unique chemical structure and biological activity.
Used in Organic Synthesis:
6-PIPERIDINONIC ACID is used as a building block in organic synthesis for its ability to contribute to the formation of complex organic molecules. Its presence in the synthesis process can enhance the properties of the final product, making it a valuable component in the creation of novel compounds.
Used in Chemical Reactions:
6-PIPERIDINONIC ACID is used as a reagent in chemical reactions, facilitating specific transformations or providing necessary intermediates. Its role in these reactions can be crucial for achieving desired outcomes in the synthesis of various chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 120800-50-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,8,0 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 120800-50:
(8*1)+(7*2)+(6*0)+(5*8)+(4*0)+(3*0)+(2*5)+(1*0)=72
72 % 10 = 2
So 120800-50-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O2/c14-11(15)9-4-5-10(12-8-9)13-6-2-1-3-7-13/h4-5,8H,1-3,6-7H2,(H,14,15)
120800-50-2Relevant academic research and scientific papers
Permeability of novel 4′-N-substituted (aminomethyl) benzoate-7-substituted nicotinic acid ester derivatives of scutellarein in Caco-2 cells and in an in vitro model of the blood-brain barrier
Ou, Yu,Luo, Min,Dong, Yong-Xi,Su, Hang,Fu, Xiao-Zhong,Cha, Yu-Feng,Zhang, Shun,Zhao, Yong-Long,Li, Yong-Jun,Wang, Yong-Lin
, p. 2205 - 2213 (2016/10/25)
A series of 4′-N-substituted (aminomethyl) benzoate-7-substituted nicotinic acid ester derivatives of scutellarein was designed and synthesized. Evaluation of physiochemical properties showed that the newly designed compounds had greater chemical stability and aqueous solubility than scutellarin or scutellarein. The permeabilities (Papp AP to BL) of compounds 7b and 7e in Caco-2 cells were 5.9-fold and 3.7-fold higher than that of scutellarin, and 3.7-fold and 2.4-fold higher than that of scutellarein. The permeabilities (Papp AP to BL) of compounds 7b and 7e in an in vitro model of the blood–brain barrier were 9.7-fold and 5.9-fold higher than that of scutellarin, and 9.2-fold and 5.6-fold higher than that of scutellarein.
